NDC 17772-103 – Trokendi XR
Topiramate 100 mg/1 · Capsule, Extended Release · Oral
Product NDC17772-103
Product details
- Brand name
- Trokendi XR
- Generic name
- topiramate
- Labeler
- Supernus Pharmaceuticals, Inc.
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA201635
- Marketed since
- August 16, 2013
- Listing expires
- December 31, 2027
Active ingredients
- Topiramate 100 mg/1
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 17772-103-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-01) | Aug 16, 2013 |
| 17772-103-07 sample | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-07) | Jun 23, 2020 |
| 17772-103-10 sample | 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-10) | Aug 16, 2013 |
| 17772-103-12 sample | 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-12) | Aug 16, 2013 |
| 17772-103-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-30) | Aug 16, 2013 |
Recalls mentioning this NDC
- D-0570-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.